3-Substituted Blatter Radicals: Cyclization of N-Arylguanidines and N-Arylamidines to Benzo[e][1,2,4]triazines and PhLi Addition | The Journal of Organic Chemistry
![3-Substituted Blatter Radicals: Cyclization of N-Arylguanidines and N-Arylamidines to Benzo[e][1,2,4]triazines and PhLi Addition | The Journal of Organic Chemistry 3-Substituted Blatter Radicals: Cyclization of N-Arylguanidines and N-Arylamidines to Benzo[e][1,2,4]triazines and PhLi Addition | The Journal of Organic Chemistry](https://pubs.acs.org/cms/10.1021/acs.joc.2c02703/asset/images/large/jo2c02703_0004.jpeg)
3-Substituted Blatter Radicals: Cyclization of N-Arylguanidines and N-Arylamidines to Benzo[e][1,2,4]triazines and PhLi Addition | The Journal of Organic Chemistry
![Malignant pheochromocytoma: current status and initiatives for future progress in: Endocrine-Related Cancer Volume 11 Issue 3 (2004) Malignant pheochromocytoma: current status and initiatives for future progress in: Endocrine-Related Cancer Volume 11 Issue 3 (2004)](https://erc.bioscientifica.com/cover/journals/erc/erc_cover.jpg)
Malignant pheochromocytoma: current status and initiatives for future progress in: Endocrine-Related Cancer Volume 11 Issue 3 (2004)
![Pharmaceutics | Free Full-Text | Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario Pharmaceutics | Free Full-Text | Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-00664/article_deploy/html/images/pharmaceutics-15-00664-g006.png?1676620846)
Pharmaceutics | Free Full-Text | Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
HTS as Sundvollhovet N-3535 Krøderen Norway Phone: +47 32 15 08 00 Fax: +47 32 14 76 46 email: info@etto.no www.etto.no / www.e
![Pharmaceutics | Free Full-Text | Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario Pharmaceutics | Free Full-Text | Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-00664/article_deploy/html/images/pharmaceutics-15-00664-g002.png?1676620842)